Hat mitgewirkt an:
-
Effekte psychiatrischer Erkrankungen auf die persönliche und sozioökonomische Krankheitslast bei neurodegenerativen Erkrankungen : Analysen am Beispiel der Parkinson-Krankheit
-
Omalizumab versus ‘Usual Care’: Results from a Naturalistic Longitudinal Study in Routine Care
-
Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease
-
Health-Related Quality of Life in Patients with a History of Myocardial Infarction and Stroke